• Media

Latest News

Display # 
Title Created Date
Cannabis Science Releases Positive Laboratory Results From Both The EU Certified As Well As Its Own Unique Cannabis Strains Grown In Its Spain Operations 28-10-14
Cannabis Science, Inc. (CBIS) Signs Drug Development and Laboratory Services Agreement with ImmunoClin Corporation (IMCL); Collaboration to Advance Clinical Studies and Formulations of the Company's Proprietary Cannabinoid Based Products 30-09-14
Cannabis Science, Inc. (CBIS) And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products 16-09-14
Cannabis Science Provides Updated Guidance on its Current Pre-Clinical Drug Development Programs Beginning with the Scientific Cannabis Cultivation Programs in Europe and North America, Testing Multiple Cannabis Strains for Multiple Critical Ailments 26-08-14
Cannabis Science, Inc. (CBIS) In Final Negotiations To Acquire British Columbia Company That Has Submitted 'Marihuana For Medical Purposes' License Application To Health Canada 25-08-14
Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 22-08-14
Cannabis Science, Inc. (CBIS) Increases Equity Position to 50.1% in Michigan Green Technologies LLC, Positioning Company as Leader in Evolving Michigan Medical Cannabis and Hemp Industries 11-08-14
Cannabis Science In Final Negotiations To Establish Its First Medical Cannabis Facilities In Canada 07-08-14
Cannabis Science, Inc. (CBIS) Encouraged by Florida Medical Cannabis Voter Support of 88 Percent; Florida Referendum in November Seen as Key Tipping Point 05-08-14
Cannabis Science Initiates Pre-Clinical Studies on Cannabinoid Formulations in Neurological Diseases Including Sleep Disorders with the Highly Reputable Institute for Health and Science on Ageing - INRCA - in Italy 04-08-14
Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 31-07-14
CBIS Very Excited Over Federal Cannabis Legalization Efforts in U.S. House and Senate to Change Medical Cannabis Laws 30-07-14
Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change 29-07-14
Cannabis Science Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (retired) for a Second Term on the Scientific Advisory Board as Special Senior Advisor to the Company 24-07-14
CFO Journal, Part of the Wall Street Journal, Addresses Business Challenges of Cannabis Industry in the Article "Pot Industry Puts on a Tie"Referencing Cannabis Science, Inc. (CBIS) Chief Financial Officer, Robert Kane 20-07-14
Cannabis Science, Inc. (CBIS) Prepares for New York State as it Becomes the 23rd State to Authorize Medical Marijuana Use 08-07-14
Cannabis Science, Inc. (CBIS) Reports Strongest Financial Position in its History, Citing Filings & Financial Statements as the Company Moves Forward with Multiple Cannabis Drug Development Programs 05-06-14
CBIS Reports on CBS News; Historic Marijuana Vote from United States House of Representatives Creates Serious Confidence as Marijuana Wins U.S. House Vote for First Time in History 03-06-14
Cannabis Science Operational Update: First Data from Preclinical Development Expected This Week; Cannabis Science Plans to Open Informational Hotline for General Public 02-06-14
Cannabis Science Cheers Dr. Oz on Becoming a Vocal Supporter of Medical Marijuana on The Larry King Live Show 27-05-14

Connect With Us

Facebook  Twitter  This email address is being protected from spambots. You need JavaScript enabled to view it. Go to USTREAM

People Behind the Scenes

Dr. Robert Melamede, Ph.D.
"The endocannabinoid system provides unique opportunities for regulating homeostasis to promote health with phyto-cannabinoid based pharmaceuticals."
Meet Dr. Robert Melamede, Ph.D. >